Examkin

Question

Difficulty: Very hardResearch Ethics and Conflicts of Interest

Match each clinical research scenario with the most appropriate ethical assessment or regulatory classification.

  • A physician accepts a direct per-capita payment from a trial sponsor strictly for referring patients to a study, independent of the patients' enrollment or the physician's effort.Ethical violation: Unacceptable financial conflict of interest (prohibited finder's fee)
  • An investigator enrolls a 14-year-old in a trial evaluating a novel acne medication after obtaining parental permission, despite the adolescent explicitly declining to participate.Ethical violation: Breach of the principle of Respect for Persons (failure to honor pediatric dissent)
  • A researcher conducts a secondary analysis of fully de-identified, unlinked retrospective medical records and leftover biospecimens without obtaining specific patient consent.Permissible practice: Secondary research exempt from informed consent requirements
  • A principal investigator submits a manuscript drafted entirely by an undisclosed medical writer employed by the pharmaceutical sponsor, signing off as the primary author.Ethical violation: Breach of publication integrity (unacknowledged ghostwriting)
  • An investigator conducts a trial comparing two standard resuscitation protocols for out-of-hospital cardiac arrest without obtaining prior consent from the incapacitated subjects.Permissible practice: Exception from informed consent (EFIC) for emergency research

Answer

Match the finder's fee to financial conflict of interest; pediatric dissent to breach of Respect for Persons; de-identified specimens to exempt secondary research; unacknowledged medical writer to ghostwriting; and cardiac arrest trial to exception from informed consent (EFIC).
Correctly matching these scenarios requires distinguishing between severe ethical violations (prohibited finder's fees, ignoring capable pediatric dissent, and ghostwriting) and permissible regulatory exceptions (exempt research on de-identified data and Exception from Informed Consent for emergency research). Each pairing aligns the specific clinical vignette with its exact regulatory or ethical mandate.

Step-by-Step Solution

1
Analyze the financial compensation scenario.
Identify that the physician is paid strictly for referrals (finder's fee).
This is universally prohibited as an unethical financial conflict of interest, distinguishing it from legitimate compensation for time and effort.
2
Evaluate the pediatric enrollment scenario.
Identify that the 14-year-old's refusal is overridden for a non-therapeutic trial.
Pediatric dissent must be honored under the principle of Respect for Persons; parental permission alone is insufficient here.
3
Assess the retrospective biospecimen scenario.
Recognize the data and specimens are fully de-identified and unlinked.
This qualifies as exempt research under the Common Rule, meaning specific patient consent is not legally or ethically required.
4
Examine the manuscript drafting scenario.
Identify the unacknowledged pharmaceutical industry writer.
This constitutes ghostwriting, which is a direct violation of transparency and publication integrity standards set by the ICMJE.
5
Evaluate the out-of-hospital cardiac arrest scenario.
Recognize the emergency nature, lack of capacity, and unavailability of surrogates.
This fits the rigorous regulatory criteria for Exception from Informed Consent (EFIC) in emergency research.

Key Concept

Application of the Common Rule, IRB regulations, and the AMA Code of Medical Ethics to resolve complex clinical research scenarios.
Rate this question

Topics

Research Ethics and Conflicts of Interest

More questions from this topic